SCHEMBL6688965

SCHEMBL6688965

COc1ccc(-c2cc(-c3ccc(OC)cc3)[o+]c(-c3ccc(OC)cc3)c2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 3/20 0.55
▸ RAB9A P51151 3/20 0.55
▸ SMN1; SMN2 Q16637 2/20 0.55
▸ TP53 P04637 1/20 0.55
▸ MAPK1 P28482 1/20 0.55
▸ CASP3 P42574 1/20 0.55
▸ SENP8 Q96LD8 1/20 0.55
▸ SENP7 Q9BQF6 1/20 0.55
▸ SENP6 Q9GZR1 1/20 0.55
▸ ABL1 P00519 3/20 0.52
▸ ABCB1 P08183 3/20 0.52
▸ BCR P11274 3/20 0.52
▸ ESR2 Q92731 1/20 0.50
▸ CA12 O43570 1/20 0.48
▸ CA1 P00915 1/20 0.48
▸ CA2 P00918 1/20 0.48
▸ CA7 P43166 1/20 0.48
▸ CA9 Q16790 1/20 0.48
▸ CA14 Q9ULX7 1/20 0.48
▸ DYRK1A Q13627 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11050461 0.92 ABL1 (0.50) NPC1RAB9ASMN1; SMN2TP53MAPK1
SCHEMBL30489763 0.92 ABL1 (0.55) NPC1RAB9ASMN1; SMN2TP53MAPK1
Perchlorate SCHEMBL11044837 0.92 NPC1 (0.51) NPC1RAB9ASMN1; SMN2TP53MAPK1
SCHEMBL6686384 0.92 ABL1 (0.55) NPC1RAB9ASMN1; SMN2TP53MAPK1
SCHEMBL6685513 0.92 ABL1 (0.55) NPC1RAB9ASMN1; SMN2TP53MAPK1
SCHEMBL7913407 0.92 ABL1 (0.55) NPC1RAB9ASMN1; SMN2TP53MAPK1
SCHEMBL29968150 0.92 ABL1 (0.55) NPC1RAB9ASMN1; SMN2TP53MAPK1
SCHEMBL30658149 0.91 NPC1 (0.49) NPC1RAB9ASMN1; SMN2TP53MAPK1
SCHEMBL11050455 0.89 NPC1 (0.46) NPC1RAB9ASMN1; SMN2TP53MAPK1
SCHEMBL10601690 0.88 ABL1 (0.50) NPC1RAB9ASMN1; SMN2TP53MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313430-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA Sicpa Holding SA (CH) 2024-02-07 — — EP claimed
CN-117098610-A Method for producing an optical effect layer comprising magnetic or magnetizable pigment particles and exhibiting more than one marking 锡克拜控股有限公司 2023-11-21 — — CN claimed
WO-2022207692-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2022-10-06 — — WO claimed
EP-1084126-B1 NOVEL VINCA-ALKALOID DERIVATIVES AND PREPARATION METHOD ROOWIN S A (FR) 2004-11-17 — — EP claimed
US-6365735-B1 ALKALOIDS FORMED BY REDUCTION OR CYANATION ROOWIN S.A. (FR) 2002-04-02 — — US claimed
EP-0213893-B1 Photopolymerisable compositions containing substituted pyrylium salts as photoinitiators; and novel pyrylium salts for use therein LOCTITE IRELAND LTD (IE) 1993-11-10 — — EP claimed
EP-4313430-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA Sicpa Holding SA (CH) 2024-02-07 — — EP disclosed
EP-4317241-A1 RANDOM COPOLYMER AND METHOD FOR MANUFACTURING SAME Zeon Corporation (JP) 2024-02-07 — — EP disclosed
CN-117098610-A Method for producing an optical effect layer comprising magnetic or magnetizable pigment particles and exhibiting more than one marking 锡克拜控股有限公司 2023-11-21 — — CN disclosed
US-20220324895-A1 DEPOLYMERIZATION AND VALORIZATION OF A BIOPOLYMER UNIV NEW YORK (US) 2022-10-13 — — US disclosed
WO-2022207692-A1 METHODS FOR PRODUCING OPTICAL EFFECT LAYERS COMPRISING MAGNETIC OR MAGNETIZABLE PIGMENT PARTICLES AND EXHIBITING ONE OR MORE INDICIA SICPA HOLDING SA (CH) 2022-10-06 — — WO disclosed
US-20170240695-A1 METATHESIS POLYMERIZATION METHODS UNIVERSITY OF WASHINGTON (US) 2017-08-24 — — US disclosed
US-20100112478-A1 WATER-DEVELOPABLE PHOTOSENSITIVE LITHOGRAPHIC PRINTING PLATE MATERIAL MITSUBISHI PAPER MILLS LIMITED (JP) 2010-05-06 — — US disclosed
EP-1084126-B1 NOVEL VINCA-ALKALOID DERIVATIVES AND PREPARATION METHOD ROOWIN S A (FR) 2004-11-17 — — EP disclosed
US-6365735-B1 ALKALOIDS FORMED BY REDUCTION OR CYANATION ROOWIN S.A. (FR) 2002-04-02 — — US disclosed
US-5900462-A DEHYDRATION REACTION OF A KETONE AND ALCOHOL; HIGH DENSITY CROSSLINKING TOYO INK MANUFACTURING CO., LTD. (JP) 1999-05-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220324895-A1 DEPOLYMERIZATION AND VALORIZATION OF A BIOPOLYMER ALG1, PPOX, MANBA NPC1 4865/4885RAB9A 3534/4885SMN1; SMN2 4547/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback